Structural determinants of sigma receptor affinity
- PMID: 2826991
Structural determinants of sigma receptor affinity
Abstract
The structural determinants of sigma receptor affinity have been evaluated by examining a wide range of compounds related to opioids, neuroleptics, and phenylpiperidine dopaminergic structures for affinity at sigma receptor-binding sites labeled with (+)-[3H]3-PPP. Among opioid compounds, requirements for sigma receptor affinity differ strikingly from the determinants of affinity for conventional opiate receptors. Sigma sites display reverse stereoselectivity to classical opiate receptors. Multi-ringed opiate-related compounds such as morphine and naloxone have negligible affinity for sigma sites, with the highest sigma receptor affinity apparent for benzomorphans which lack the C ring of opioids. Highest affinity among opioids and other compounds occurs with more lipophilic N-substituents. This feature is particularly striking among the 3-PPP derivatives as well as the opioids. The butyrophenone haloperidol is the most potent drug at sigma receptors we have detected. Among the series of butyrophenones, receptor affinity is primarily associated with the 4-phenylpiperidine moiety. Conformational calculations for various compounds indicate a fairly wide range of tolerance for distances between the aromatic ring and the amine nitrogen, which may account for the potency at sigma receptors of structures of considerable diversity. Among the wide range of structures that bind to sigma receptor-binding sites, the common pharmacophore associated with high receptor affinity is a phenylpiperidine with a lipophilic N-substituent.
Similar articles
-
Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.J Pharmacol Exp Ther. 1986 Aug;238(2):739-48. J Pharmacol Exp Ther. 1986. PMID: 3016248
-
Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.J Pharmacol Exp Ther. 1986 May;237(2):681-8. J Pharmacol Exp Ther. 1986. PMID: 3009795
-
Receptor site topographies for phencyclidine-like and sigma drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analyses.Mol Pharmacol. 1988 Dec;34(6):863-79. Mol Pharmacol. 1988. PMID: 2849051
-
[Stereostructure-activity relation of morphinics. Topology of the mu receptor and nature of the opioid pharmacophore].J Pharm Belg. 1989 Jan-Feb;44(1):71-83. J Pharm Belg. 1989. PMID: 2542515 Review. French.
-
Dextromethorphan sites, sigma receptors, and the psychotomimetic effects of sigma opiates.Prog Clin Biol Res. 1990;328:13-6. Prog Clin Biol Res. 1990. PMID: 2154766 Review.
Cited by
-
The Sigma Enigma: A Narrative Review of Sigma Receptors.Cureus. 2023 Mar 4;15(3):e35756. doi: 10.7759/cureus.35756. eCollection 2023 Mar. Cureus. 2023. PMID: 37020478 Free PMC article. Review.
-
Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics.Int J Mol Sci. 2022 Mar 2;23(5):2766. doi: 10.3390/ijms23052766. Int J Mol Sci. 2022. PMID: 35269909 Free PMC article. Review.
-
Identification of SARS-CoV-2 entry inhibitors among already approved drugs.Acta Pharmacol Sin. 2021 Aug;42(8):1347-1353. doi: 10.1038/s41401-020-00556-6. Epub 2020 Oct 28. Acta Pharmacol Sin. 2021. PMID: 33116249 Free PMC article.
-
Cocaine-induced endocannabinoid signaling mediated by sigma-1 receptors and extracellular vesicle secretion.Elife. 2019 Oct 9;8:e47209. doi: 10.7554/eLife.47209. Elife. 2019. PMID: 31596232 Free PMC article.
-
Affinity of fentanyl and its derivatives for the σ1-receptor.Medchemcomm. 2019 Jun 13;10(7):1187-1191. doi: 10.1039/c9md00222g. eCollection 2019 Jul 1. Medchemcomm. 2019. PMID: 31391893 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources